IL203051A - Use of alpha-ketoglutarate for drug preparation - Google Patents

Use of alpha-ketoglutarate for drug preparation

Info

Publication number
IL203051A
IL203051A IL203051A IL20305109A IL203051A IL 203051 A IL203051 A IL 203051A IL 203051 A IL203051 A IL 203051A IL 20305109 A IL20305109 A IL 20305109A IL 203051 A IL203051 A IL 203051A
Authority
IL
Israel
Prior art keywords
ketoglutarate
medicaments
alpha
preparation
Prior art date
Application number
IL203051A
Other languages
English (en)
Hebrew (he)
Original Assignee
Danuta Kruszewska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP07460015A external-priority patent/EP1917959B1/en
Application filed by Danuta Kruszewska filed Critical Danuta Kruszewska
Publication of IL203051A publication Critical patent/IL203051A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
IL203051A 2007-07-03 2009-12-30 Use of alpha-ketoglutarate for drug preparation IL203051A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07460015A EP1917959B1 (en) 2006-07-03 2007-07-03 New medical use of alfa-ketoglutarate
PCT/PL2007/000086 WO2009005379A1 (en) 2007-07-03 2007-12-31 New medical applications of alpha-ketoglutarate

Publications (1)

Publication Number Publication Date
IL203051A true IL203051A (en) 2014-07-31

Family

ID=39322797

Family Applications (1)

Application Number Title Priority Date Filing Date
IL203051A IL203051A (en) 2007-07-03 2009-12-30 Use of alpha-ketoglutarate for drug preparation

Country Status (5)

Country Link
JP (2) JP5518702B2 (zh)
KR (2) KR20150003908A (zh)
CN (2) CN102014888A (zh)
IL (1) IL203051A (zh)
WO (1) WO2009005379A1 (zh)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201400567QA (en) 2011-10-11 2014-05-29 Medimmune Llc Cd40l-specific tn3-derived scaffolds and methods of use thereof
CN103168972A (zh) * 2013-04-19 2013-06-26 中国水产科学研究院黑龙江水产研究所 一种提高鲤鱼生长性能和蛋白质沉积的饲料
RU2673473C2 (ru) * 2013-12-27 2018-11-27 Колгейт-Палмолив Компани Пребиотические композиции для ухода за полостью рта, содержащие карбоновые кислоты
CN104257643B (zh) * 2014-09-15 2016-09-21 华南理工大学 基于α-酮戊二酸的泌尿系磷酸盐结石的溶石剂及其制备方法
CN104721176B (zh) * 2015-02-02 2018-07-10 中山大学 α-酮戊二酸在提高细菌对抗生素敏感性方面的应用
EP3268389B1 (en) 2015-03-12 2020-09-30 Medimmune, LLC Method of purifying albumin-fusion proteins
CN105325731A (zh) * 2015-12-07 2016-02-17 湖南农业大学 α-酮戊二酸作为饲料添加剂的用途及相应饲料
CN105475230B (zh) * 2015-12-17 2018-04-20 中国农业大学 一种提高大龄动物繁殖力的方法
LU100900B1 (de) * 2018-08-10 2020-02-17 Thomas Melchior Homann Verbindungen zur modulation von a-ketoglutarsäure (2kg)-abhängigen oxygenasen
JP2022504792A (ja) * 2018-10-10 2022-01-13 セルバトゥス リミテッド 炎症性疾患及び関連する感染の治療方法
AU2020292062B2 (en) * 2019-06-14 2024-01-18 Cj Cheiljedang Corporation Composition for preventing, treating, or improving gastrointestinal diseases comprising strain of genus Corynebacterium and culture thereof
WO2021136765A1 (en) * 2019-12-30 2021-07-08 Devicare, S.L. Compositions for clinical complications associated to devices implanted in the urinary tract
CN111067885A (zh) * 2020-02-20 2020-04-28 杨益文 一种消除幽门螺旋螺杆菌及治疗胃及十二指肠溃疡的药物
CN111820330A (zh) * 2020-07-17 2020-10-27 禹城保立康生物饲料有限公司 一种提高哺乳仔猪发育的母猪饲料
CN113337436A (zh) * 2021-06-09 2021-09-03 中国科学院新疆生态与地理研究所 一种尿素分解菌及其选育方法和应用
CN113995054A (zh) * 2021-11-02 2022-02-01 中国科学院亚热带农业生态研究所 鸟氨酸-α-酮戊二酸在制备促进保育猪生长饲料中的应用
CN115340313B (zh) * 2022-01-17 2023-04-18 浙江理工大学 一种物理复合微生物技术强化再生骨料方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4919855B1 (zh) * 1970-10-06 1974-05-21
SE9303691D0 (sv) * 1993-11-09 1993-11-09 Gramineer Ab New beverage
JP2002529545A (ja) * 1998-11-06 2002-09-10 ユニベルシテ ドゥ モントリオール バイオフィルムを除去するための改良型の殺菌性及び非殺菌性溶液
JP4533496B2 (ja) * 2000-03-15 2010-09-01 三菱重工業株式会社 バイオマスからの燃料製造方法
EP1184443A1 (en) * 2000-09-04 2002-03-06 Biofuel B.V. Process for the production of liquid fuels from biomass
FR2822704B1 (fr) * 2001-03-29 2005-02-18 Chiesi Sa Sels de cetoacides et d'acides amines gastroresistants et leur utilisation pour la preparation de medicaments
SE0200256D0 (sv) * 2001-12-21 2002-01-29 Gramineer Internat Ab New composition, methods and use
PL368572A1 (en) * 2004-06-17 2005-12-27 Sgp & Sons Ab Pharmaceutical compound for prevention and therapy of increased level of cholesterol, ldl and triglycerides as well as application of the pharmaceutical compound as an agent acting against atherosclerosis and used in circulatory system affections
EP1778616A1 (en) * 2004-08-09 2007-05-02 Cancer Research Technology Limited Alpha-ketoglutarates and their use as therapeutic agents
WO2006043336A1 (ja) * 2004-10-20 2006-04-27 Kotobuki Pharmaceutical Co., Ltd. 胃粘膜疾患の治療又は予防のための組成物
US7803817B2 (en) * 2005-05-11 2010-09-28 Vecta, Ltd. Composition and methods for inhibiting gastric acid secretion

Also Published As

Publication number Publication date
KR20150003908A (ko) 2015-01-09
JP5518702B2 (ja) 2014-06-11
CN104825433A (zh) 2015-08-12
KR20100053546A (ko) 2010-05-20
JP2014193866A (ja) 2014-10-09
JP2010532347A (ja) 2010-10-07
KR101610791B1 (ko) 2016-04-11
CN102014888A (zh) 2011-04-13
WO2009005379A1 (en) 2009-01-08

Similar Documents

Publication Publication Date Title
IL203051A (en) Use of alpha-ketoglutarate for drug preparation
IL226702A (en) Therapeutic isoxazole compounds for drug preparation
HK1211889A1 (zh) 二氨基吩噻嗪的治療用途
EP2211620A4 (en) THERAPEUTIC COMPOUNDS
HK1141013A1 (en) Process for the preparation of certain substituted sulfilimines
IL210549A (en) Pipedrine - Quinocosalin-Mediated Conjugated Drugs
GB0716532D0 (en) Therapeutic compounds
GB0813087D0 (en) Therapeutic compounds
EP2164324A4 (en) THERAPEUTIC COMPOUNDS
ZA200907191B (en) Process for the preparation of gefitiib
GB0721332D0 (en) Medicaments
HK1161555A1 (zh) 抗催乳素獸醫學組合物在製備藥物中的用途
IL199697A0 (en) Therapeutical uses of eslicarbazepine
GB0715790D0 (en) Drug combination for the treatment of sialorrhoea
EP2185568A4 (en) THERAPEUTIC COMPOUNDS
HUP0700756A2 (en) Process for the preparation of pharmaceutical intermediers
EP2157089A4 (en) THERAPEUTIC USES OF IMIDAZOL-5-CARBOXYLIC ACID DERIVATIVES
GB2464854B (en) Process for the preparation of risperidone
GB0702862D0 (en) Therapeutic compounds
SI2219611T1 (sl) Farmacevtske oblike za sproĺ äśanje aktivnih spojin
GB0717450D0 (en) Medicament
GB0721333D0 (en) Medicaments
GB0708188D0 (en) Therapeutic compounds
GB0717571D0 (en) Therapeutic compounds
GB0717572D0 (en) Therapeutic compounds

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees